U.S. Healthcare Services Stock News

South Plains Financial (SPFI) opened Q2 2026 with total revenue of US$64.1 million and basic EPS of US$0.99, putting fresh numbers on the table for investors watching its profitability story. The company reported quarterly revenue of US$52.2 million in Q2 2025 and US$64.1 million in Q2 2026, while basic EPS was US$0.90 and US$0.99 over the same periods, providing a reference point for how the top and bottom lines are tracking into this year. With these results, attention turns to how South...

Zai Lab (ZLAB) is back in focus after a recent share price move, with the stock closing at US$20.20. Investors are weighing this level against the company’s current fundamentals and recent performance. See our latest analysis for Zai Lab. Over a longer window, Zai Lab’s 11.11% 1 month share price return contrasts with a decline of 20% over 3 months and a 39.83% fall in 1 year total shareholder return. This suggests recent momentum is attempting to recover following a weak stretch. If you are...

Adobe (ADBE) is drawing attention after posting eight consecutive quarters of revenue growth while managing executive transitions and pushing AI deeper into its software. This combination stands out as recurring revenue margins come under pressure. See our latest analysis for Adobe. Despite the latest 1-month share price return of 21.57% and a 7-day share price return of 6.09%, Adobe’s year to date share price return is down 28.82%, and the 1-year total shareholder return has declined 35.14%...

Goodwall recently expanded its partnership with HP Inc. to extend HP devices and AI skills programs across Brazil and Latin America, including AI Fundamentals and the NextGen AI Alliance, with content now available in Brazilian Portuguese and Spanish. The initiative has already reached more than two million young people in over 180 countries and awarded over 151,000 HP-branded credentials, aligning HP with large-scale AI education and future workforce development. Next, we’ll examine how...

Dell Technologies (DELL) recently amended its bylaws to opt into Section 21.373 of the Texas Business Organizations Code, setting specific ownership, holding period, and solicitation thresholds for shareholders who want to submit proposals. See our latest analysis for Dell Technologies. Those bylaw changes arrive after a sharp run up in Dell Technologies, with the share price at $396.34 and a very large year to date share price return of 210.13%, alongside a multi year total shareholder...

Markets are sending mixed signals right now, with softer inflation readings, uneven housing data and shifting global bond flows all pulling your portfolio in different directions. When headlines are noisy, low risk leaders with strong balance sheets can help you stay invested without leaning on guesswork about the next macro swing. Our Low-Risk Leaders screener focuses on companies that our model scores as having the lowest risk profiles, so you can concentrate on resilient businesses instead...

IMAX (IMAX) is back in focus after two catalysts: the upcoming Christopher Nolan film "The Odyssey," shot entirely on IMAX 70mm cameras, and a new in-vehicle entertainment partnership with Goer Dynamics and IMAX China. See our latest analysis for IMAX. After a softer 30 day share price return, down 11.46%, IMAX is still showing renewed interest, with a 90 day share price return of 9.18% and a 1 year total shareholder return of 38.11%, supported by fresh content and platform expansion news. If...

PNC Financial Services Group has delivered a strong 108.8% share price return over the past 3 years, and the current valuation picture now hinges on how that rally lines up with its intrinsic value estimate and broader checks. The 108.8% 3 year return suggests investors have already priced in a meaningful improvement in PNC Financial Services Group's earnings power. Recent earnings growth, a higher dividend, and ongoing technology investment can support higher valuations, while integration...

Kura Oncology previously announced that updated Phase 1a results from its FIT-001 trial of darlifarnib plus cabozantinib in advanced renal cell carcinoma were selected for an oral presentation at the 2026 Kidney Cancer Research Summit in Boston. The data highlight darlifarnib’s potential to enhance VEGFR-targeted therapies by inhibiting adaptive mTORC1 signaling, supporting Kura’s plan to position it as a precision combination backbone across multiple targeted therapy classes. We’ll now...

Investor Letter Puts Extreme Networks Back in Focus Extreme Networks (EXTR) drew fresh attention after Madison Small Cap Fund highlighted the company in its Q2 2026 investor letter, citing its cloud-managed, software-defined platform and differentiation against larger networking competitors. The fund also pointed to industry shifts toward Wi-Fi 7 and broader AI deployments as potential drivers for Extreme Networks’ hardware and software management solutions, a backdrop that has coincided with...

In July 2026, AECOM announced a series of major contract wins, including roles on Queensland’s The Wave rail project, Canada’s Alexandra Bridge replacement, and Thames Water’s approximately £340 million Oxford Sewage Treatment Works upgrade. These appointments highlight AECOM’s growing involvement in complex, digitally delivered transport and water projects that are tightly linked to regulatory, sustainability and infrastructure-planning priorities across multiple regions. We’ll now examine...

New York’s one year moratorium on environmental permits for large data centers has pushed power constraints into focus, putting Constellation Energy (CEG) under closer investor scrutiny as AI driven electricity demand meets regulatory limits. See our latest analysis for Constellation Energy. Constellation Energy’s share price has cooled recently, with the stock down 7.9% over the past month and 12.2% over the past quarter, while its 1 year total shareholder return is down 21.1% after a very...

Why Mondelez International’s sustainable packaging move matters for investors Mondelez International (MDLZ) has drawn fresh attention after partners announced a new flexible packaging solution for its Marabou chocolate bars, using circular polymers sourced from mixed plastic waste. The collaboration with LyondellBasell, Amcor and Taghleef Industries enables Mondelez to use packaging with 75% attributed recycled content. This development aligns its European confectionery business with...

Earlier this week, Moonshot AI’s Kimi K3 autonomously designed a functional semiconductor chip in 48 hours using only open-source design tools, avoiding established Electronic Design Automation vendors such as Synopsys. The achievement raises fresh questions about how open-source, AI-driven chip design might affect long-term demand for Synopsys’s proprietary software platforms. We’ll now examine how the emergence of AI-driven, open-source chip design tools could influence Synopsys’s...

Upcoming earnings and buyback program put TKO Group Holdings (TKO) in focus TKO Group Holdings (TKO) heads into its August 3 fiscal 2026 Q2 earnings release with investor attention on forecasts for a 47% profit per share increase and an $800 million accelerated share repurchase that was recently completed. See our latest analysis for TKO Group Holdings. At a share price of $185.13, TKO Group Holdings has seen its short term momentum cool, with a 30 day share price return of negative 6.87%...

Align Technology, Inc. previously announced that Executive Vice President and Chief Legal and Regulatory Officer Julie Coletti will resign effective August 1, 2026, to become Chief Legal Officer at Illumina, Inc. This leadership change in a core legal and regulatory role may matter for how investors think about Align’s governance, risk oversight, and long-term execution. Next, we’ll examine how the departure of Align’s Chief Legal and Regulatory Officer could shape the company’s broader...

SELLAS Life Sciences Group stock has delivered a very large three year return while the broader valuation checks suggest the shares are expensive rather than a clear bargain. Over the past three years, SELLAS Life Sciences Group has returned about 7x, which puts extra attention on whether the current price already reflects much of the good news. Expectations for rapid revenue and earnings growth may support the current valuation, while the recently filed US$154.6m shelf registration...

Tariff headlines are no longer just background noise for investors. With trans-Pacific shipping demand cooling, freight rates under pressure and importers hesitating on orders, the latest round of U.S. trade uncertainty is starting to bite specific stocks tied to Asia to U.S. supply chains. For some companies, stalled shipments and a pulled-forward peak season could mean tougher volumes, uneven pricing power and more complex inventory choices. This article explains how that news risk affects...

Hingham Institution for Savings (HIFS) opened Q2 2026 with total revenue of US$42.4 million and basic EPS of US$11.59, supported by net income of US$25.4 million, setting a clear earnings tone for the quarter. The bank has seen quarterly revenue move from US$20.4 million and EPS of US$4.32 in Q2 2025 to US$34.5 million with EPS of US$9.49 in Q4 2025, before reaching the latest Q2 2026 levels, while trailing twelve month EPS stood at US$30.33 on revenue of US$119.5 million. With a reported net...

Gibraltar Industries (NasdaqGS:ROCK) has completed the sale of its Renewables business. The company is repositioning around core markets including residential, agtech, and infrastructure. The transaction reshapes Gibraltar Industries’ business mix and long term focus. The exit from renewables marks a clear refocus for Gibraltar Industries, which now centers its portfolio on residential products, controlled environment agriculture, and infrastructure solutions. For investors, this means the...

Why recent product and partnership moves matter for PTC stock PTC (PTC) has been busy on several fronts, launching the Onshape Labs early access program for AI features, expanding into hospital based 3D printed implants, and teaming up with Whatfix on Product Lifecycle Management adoption. See our latest analysis for PTC. Despite the recent product launches and partnerships, PTC’s share price has fallen about 27% year to date and the 1 year total shareholder return is down about 38%. Recent...

Sionna Therapeutics stock has delivered a sharp 195.2% return over the past year, yet its low value score and overvalued reading on the market multiples raise questions about how much upside is already reflected in the price. Over the past 1 year, Sionna Therapeutics has returned 195.2%, which puts the recent share price strength firmly in focus for anyone thinking about valuation. Expectations for the company’s drug pipeline can support a premium, but uncertainty around execution,...

Travel + Leisure stock has delivered a 96.3% return over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings-based multiples still point to the shares trading at a discount to what the business may be worth. With the stock recently at US$73.27 and fresh acquisition news in play, the central question is whether the current price already reflects that upside. Over the last three years, Travel + Leisure has returned 96.3%, which puts extra focus...

Earlier this month, Costco Wholesale reported that net sales for June reached US$29.24 billion for the five weeks ended July 5, 2026, a 10.6% increase from the same period last year. This performance underlines how Costco’s membership-fee model and recurring cash flows continue to underpin its ability to fund regular dividends, including the recently declared US$1.47 per-share quarterly payout due in August. We’ll now examine how June’s double-digit sales growth and membership-driven cash...